Findings from a study recently published in Proceedings of the National Academy of Sciences of the United States of America illustrates how cannabinoid signaling may regulate the stress response in the brain. In a series of experiments performed in in vitro and ex vivo models, researchers from Vanderbilt University and Northwestern University, found that cannabinoid signaling…

Cannabidiol (CBD)’s anti-inflammatory properties appear to be related to its role as a lipid mediator (LM) class-switching agent that promotes the production of specialized pro-resolving mediators (SPMs) while suppressing the production of pro-inflammatory products according to a study published in Cell Chemical Biology. German researchers set out to uncover the anti-inflammatory mechanism of action for…

Smoking cannabis may slow inflammation associated with the onset of  age-related macular degeneration (AMD), according to research published in Journal Français d’Ophtalmologie. However, cannabis smokers who do develop AMD are diagnosed at significantly younger ages than those who do not use the drug, according to the study.  Researchers enrolled 419 participants (mean age, 56±8 years; 54% women)…

Findings from a recently published study in Frontiers in Neuroscience shed light on how a low dose of delta-9-tetrahydrocannabinol (THC) may provide neuroprotective effects in older mice. Researchers from Tel Aviv University employed a mouse model to test the effects of a very small dose of THC (0.002 mg/kg) on the aging brain and compared it…

A new study has determined that between 2013 and 2020, use of medical cannabis for a variety of conditions increased across the United States. The study, published in the American Journal of Preventive Medicine, found an average annual percentage increase of 12.9% during this 8-year period. “Although the Controlled Substances Act of 1971 designates cannabis…